N. Uyama, H. Otsuka, T. Shinya, Y. Otomi, M. Harada et al., The utility of the combination of a SPECT study with [123I]--FP--CIT of dopamine transporters and [123I]--MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes, Nucl Med Commun. juin, vol.38, issue.6, pp.487-92, 2017.

A. Lebasnier, G. Lamotte, A. Manrique, D. Peyronnet, G. Bouvard et al., Potential diagnostic value of regional myocardial adrenergic imaging using (123)I--MIBG SPECT to identify patients with Lewy body diseases, Eur J Nucl Med Mol Imaging. juin, vol.42, issue.7, pp.1043-51, 2015.

J. Spiegel, Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease, Parkinsons Dis, p.295346, 2010.

T. Amino, S. Orimo, Y. Itoh, A. Takahashi, T. Uchihara et al., Profound cardiac sympathetic denervation occurs in Parkinson disease, Brain Pathol. janv, vol.15, issue.1, pp.29-34, 2005.

G. Lamotte, R. Morello, A. Lebasnier, D. Agostini, and G. L. Defer, Accuracy and cutoff values of delayed heart to mediastinum ratio with (123)I--metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses, BMC Neurol. 15 mai, vol.15, p.83, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02052612

A. Flotats, I. Carrió, D. Agostini, L. Guludec, D. Marcassa et al., Proposal for standardization of 123I--metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology, Eur J Nucl Med Mol Imaging. août, vol.37, issue.9, pp.1802-1814, 2010.

Y. Takahashi, M. Miyagawa, Y. Nishiyama, H. Ishimura, and T. Mochizuki, Performance of a semiconductor SPECT system: comparison with a conventional Anger--type SPECT instrument, Ann Nucl Med. janv, vol.27, issue.1, pp.11-17, 2013.

T. Blaire, A. Bailliez, B. Bouallegue, F. Bellevre, D. Agostini et al., First assessment of simultaneous dual isotope (123I/99mTc) cardiac SPECT on two different CZT cameras: A phantom study, J Nucl Cardiol. oct, vol.25, issue.5, pp.1692-704, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01777803

D. Bellevre, A. Manrique, D. Legallois, S. Bross, R. Baavour et al., First determination of the heart--to--mediastinum ratio using cardiac dual isotope ( 123 I--MIBG/ 99 mTc--tetrofosmin) CZT imaging in patients with heart failure: the ADRECARD study, Eur J Nucl Med Mol Imaging, vol.42, issue.12, pp.1912-1921, 2015.

T. Blaire, A. Bailliez, B. Bouallegue, F. Bellevre, D. Agostini et al., Determination of the Heart--to--Mediastinum Ratio of 123I--MIBG Uptake Using Dual--Isotope (123I--MIBG/99mTc--Tetrofosmin) Multipinhole Cadmium--Zinc--Telluride SPECT in Patients with Heart Failure, J Nucl Med. févr, vol.59, issue.2, pp.251-259, 2018.

K. K. Solanki, J. Bomanji, J. Moyes, S. J. Mather, P. J. Trainer et al., A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta--iodobenzylguanidine (MIBG), Nucl Med Commun. juill, vol.13, issue.7, pp.513-534, 1992.

P. H. Lee, J. S. Kim, D. H. Shin, S. Yoon, and K. Huh, Cardiac 123I--MIBG scintigraphy in patients with drug induced parkinsonism, J Neurol Neurosurg Psychiatry. mars, vol.77, issue.3, pp.372-376, 2006.

I. G. Mckeith, B. F. Boeve, D. W. Dickson, G. Halliday, J. Taylor et al., Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium, Neurology, vol.89, issue.1, pp.88-100, 2017.

G. U. Höglinger, G. Respondek, M. Stamelou, C. Kurz, K. A. Josephs et al., Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria, Mov Disord, vol.32, issue.6, pp.853-64, 2017.

R. B. Postuma, D. Berg, M. Stern, W. Poewe, C. W. Olanow et al., MDS clinical diagnostic criteria for Parkinson's disease, Mov Disord, vol.30, issue.12, pp.1591-601, 2015.

M. J. Armstrong, I. Litvan, A. E. Lang, T. H. Bak, K. P. Bhatia et al., Criteria for the diagnosis of corticobasal degeneration, Neurology. 29 janv, vol.80, issue.5, pp.496-503, 2013.

S. Gilman, G. K. Wenning, P. A. Low, D. J. Brooks, C. J. Mathias et al., Second consensus statement on the diagnosis of multiple system atrophy, Neurology. 26 août, vol.71, issue.9, pp.670-676, 2008.

T. Blaire, A. Bailliez, F. B. Bouallegue, D. Bellevre, D. Agostini et al., Left ventricular function assessment using 123I/99mTc dual--isotope acquisition with two semi--conductor cadmium--zinc--telluride (CZT) cameras: a gated cardiac phantom study, EJNMMI Phys. déc, vol.3, issue.1, p.27, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01815107

J. M. Bland and D. G. Altman, Statistical methods for assessing agreement between two methods of clinical measurement, Lancet. 8 févr, vol.1, issue.8476, pp.307-317, 1986.

H. Takatsu, H. Nishida, H. Matsuo, S. Watanabe, K. Nagashima et al., Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG, J Nucl Med. janv, vol.41, issue.1, pp.71-78, 2000.

M. Estorch, I. Carrió, L. Berná, J. López--pousa, and G. Torres, Myocardial iodine--labeled metaiodobenzylguanidine 123 uptake relates to age, J Nucl Cardiol. avr, vol.2, issue.2, pp.126-158, 1995.